Related Experiment Videos
Summary
Leukemia during pregnancy poses significant risks, with acute forms leading to 100% maternal mortality. Management focuses on achieving remission for fetal survival, while advances may reduce pregnancy-leukemia associations.
Area of Science:
- Hematology
- Obstetrics
- Gynecology
Background:
- Leukemia complicates pregnancy, presenting in acute and chronic forms.
- Acute leukemia has a 100% maternal mortality rate, while chronic leukemia has a 36.5% rate.
- Perinatal mortality ranges from 16.2% in chronic leukemia to 34-36% in acute leukemia.
Purpose of the Study:
- To review the clinical considerations, maternal and perinatal outcomes, and management strategies for leukemia in pregnancy.
- To discuss the risks associated with chemotherapy and irradiation during pregnancy.
- To explore factors that may decrease the incidence of leukemia in pregnancy.
Main Methods:
- Literature review of studies on leukemia and pregnancy.
- Analysis of maternal and perinatal mortality rates.
- Discussion of treatment implications and potential long-term effects.
Main Results:
- Maternal mortality is 100% for acute leukemia and 36.5% for chronic leukemia.
- Perinatal mortality is significantly higher in acute leukemia (34-36%) compared to chronic leukemia (16.2%).
- Postpartum hemorrhage incidence can be as high as 83% in some cases.
Conclusions:
- Management aims to achieve remission for fetal viability, balancing maternal health and fetal risks.
- Chemotherapy and irradiation in pregnancy require caution due to unknown genetic damage and potential long-term effects.
- Advances in reproductive health and cancer treatment may reduce the occurrence of leukemia in pregnancy.